Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.
Kawaguchi T, Koh Y, Ando M, Ito N, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Serizawa M, Tamiya A, Shimizu S, Yoshimoto N, Kubo A, Isa S, Saka H, Matsumura A. Kawaguchi T, et al. Among authors: kakegawa s. J Clin Oncol. 2016 Jul 1;34(19):2247-57. doi: 10.1200/JCO.2015.64.2322. Epub 2016 May 9. J Clin Oncol. 2016. PMID: 27161973
Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
Watanabe M, Kawaguchi T, Isa S, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y. Watanabe M, et al. Among authors: kakegawa s. Clin Cancer Res. 2015 Aug 1;21(15):3552-60. doi: 10.1158/1078-0432.CCR-14-2151. Epub 2015 Apr 16. Clin Cancer Res. 2015. PMID: 25882755
Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I. Kakegawa S, et al. Cancer. 2011 Sep 15;117(18):4257-66. doi: 10.1002/cncr.26010. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387273 Free article.
Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma.
Araki T, Shimizu K, Nakamura T, Baba M, Kawai Y, Nakamura K, Mitani Y, Obayashi K, Aomori T, Fujita Y, Miyamae Y, Kakegawa S, Kaira K, Lezhava A, Hayashizaki Y, Takeyoshi I, Yamamoto K. Araki T, et al. Among authors: kakegawa s. Oncol Rep. 2011 Nov;26(5):1213-9. doi: 10.3892/or.2011.1391. Epub 2011 Jul 15. Oncol Rep. 2011. PMID: 21769434
Clinicopathological and therapeutic significance of CXCL12 expression in lung cancer.
Imai H, Sunaga N, Shimizu Y, Kakegawa S, Shimizu K, Sano T, Ishizuka T, Oyama T, Saito R, Minna JD, Mori M. Imai H, et al. Among authors: kakegawa s. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1):153-64. doi: 10.1177/039463201002300114. Int J Immunopathol Pharmacol. 2010. PMID: 20378003 Free PMC article.
Clinicopathological and prognostic significance of interleukin-8 expression and its relationship to KRAS mutation in lung adenocarcinoma.
Sunaga N, Kaira K, Tomizawa Y, Shimizu K, Imai H, Takahashi G, Kakegawa S, Ohtaki Y, Nagashima T, Kasahara N, Kawashima O, Hisada T, Saito R, Yamada M. Sunaga N, et al. Among authors: kakegawa s. Br J Cancer. 2014 Apr 15;110(8):2047-53. doi: 10.1038/bjc.2014.110. Epub 2014 Feb 27. Br J Cancer. 2014. PMID: 24577055 Free PMC article.
Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.
Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I. Miyamae Y, et al. Among authors: kakegawa s. J Mol Diagn. 2010 Mar;12(2):257-64. doi: 10.2353/jmoldx.2010.090105. Epub 2010 Jan 21. J Mol Diagn. 2010. PMID: 20093389 Free PMC article.
66 results